TABLE 1.

Zika virus peptide inhibitors.

Inhibitor	Sequence	Testing model	Cell lines	IC50 (μM)	CC50 (μM)	References
Peptide Z2	MAVLGDTAWDF	in vitro	BHK21 cells	1.75 ± 0.13	–	Yu et al. (2017)
	GSVGGALNSLG			3.69 ± 0.27
	KGIHQIFGAAF		Vero cells
P5	GQASNGVFVIH	in vitro	Vero cells	3.27	–	Chen et al. (2017)
	WGKFDSFGIAV
Ev37	GLINEKKVQQYLDE	in vitro	Huh-7 cells	–	–	Li et al. (2019)
	KLPNGVVKGALKSL
	VHKAAKNQNLCAF
	NVDTVGMCDADCK
	RQGKAKGVCHGT
	KCKCDVELSYKK
Aprotinin	–	in vitro	–	0.07 ± 0.012	–	Shiryaev et al. (2017)
Acyl-KR-aldehyde	–	–	–	0.208	–	Li et al. (2017d)
AH-D peptide	SGSWLRDVWDWIC	in vivo	In mouse	0.0119	–	Cho et al. (2009), Jackman et al. (2018)
	TVLTDFKTWLQSKL
FFAAP	FFAAP	in vitro	Human JEG-3 cells Vero cells		–	Margueron and Reinberg (2011), Di Croce and Helin (2013), Kim et al. (2015), Vasireddi et al. (2019)
ZMP STE24	–	in vitro	T98-G cells	–	–	Fu et al. (2017)